BACKGROUND: Elevated plasma homocysteine (Hcy) is considered to be a risk factor of coronary artery disease (CAD), although this is still controversially discussed. This study investigated the role of Hcy in young patients with CAD in southern China. METHODS: A total of 146 consecutive patients (aged ≤ 55 years) with angiographically proven CAD were enrolled in the study and 138 age-matched non-CAD individuals were included as the control group. Hcy levels were measured by enzymatic assay. Hyperhomocysteinemia (HHcy) was defined as Hcy ≥ 15 µmol/l. A 10-year CAD risk was calculated using the Framingham risk score (FRS) modified according to the National Cholesterol Education Program Adult Treatment Panel III. RESULTS: There were significant differences between the CAD and control groups with regard to male sex (P < 0.01), smoking history (P < 0.05), and triglyceride levels (TG, P < 0.05), but no remarkable difference in other conventional risk factors (all P > 0.05). Hcy and high-sensitivity C-reactive protein (hs-CRP) levels were significantly higher in the CAD group than those in the control group (both P < 0.05). The FRS and estimated 10-year absolute CAD event risk were low in both groups and did not show a statistical difference. Multivariate logistic regression showed that male sex (odds ratio, OR, 3.68; 95 % confidence interval, 95 % CI, 1.54-10.01), smoking (OR, 2.54; 95 % CI, 1.15-5.36), TG (OR, 1.30; 95 % CI, 1.08-3.06), hs-CRP (OR, 3.74; 95 % CI, 1.72-12.21), and HHcy (OR, 2.03; 95 % CI, 1.26-5.83) were independently correlated with CAD in young patients. CONCLUSION: HHcy is an important independent risk factor for CAD in young patients in southern China after adjusting for other risk factors.
BACKGROUND: Elevated plasma homocysteine (Hcy) is considered to be a risk factor of coronary artery disease (CAD), although this is still controversially discussed. This study investigated the role of Hcy in young patients with CAD in southern China. METHODS: A total of 146 consecutive patients (aged ≤ 55 years) with angiographically proven CAD were enrolled in the study and 138 age-matched non-CAD individuals were included as the control group. Hcy levels were measured by enzymatic assay. Hyperhomocysteinemia (HHcy) was defined as Hcy ≥ 15 µmol/l. A 10-year CAD risk was calculated using the Framingham risk score (FRS) modified according to the National Cholesterol Education Program Adult Treatment Panel III. RESULTS: There were significant differences between the CAD and control groups with regard to male sex (P < 0.01), smoking history (P < 0.05), and triglyceride levels (TG, P < 0.05), but no remarkable difference in other conventional risk factors (all P > 0.05). Hcy and high-sensitivity C-reactive protein (hs-CRP) levels were significantly higher in the CAD group than those in the control group (both P < 0.05). The FRS and estimated 10-year absolute CAD event risk were low in both groups and did not show a statistical difference. Multivariate logistic regression showed that male sex (odds ratio, OR, 3.68; 95 % confidence interval, 95 % CI, 1.54-10.01), smoking (OR, 2.54; 95 % CI, 1.15-5.36), TG (OR, 1.30; 95 % CI, 1.08-3.06), hs-CRP (OR, 3.74; 95 % CI, 1.72-12.21), and HHcy (OR, 2.03; 95 % CI, 1.26-5.83) were independently correlated with CAD in young patients. CONCLUSION: HHcy is an important independent risk factor for CAD in young patients in southern China after adjusting for other risk factors.
Authors: Pasquale Perrone-Filardi; Stephan Achenbach; Stefan Möhlenkamp; Zeljko Reiner; Gianmario Sambuceti; Joanne D Schuijf; Ernst Van der Wall; Philip A Kaufmann; Juhani Knuuti; Stephen Schroeder; Michael J Zellweger Journal: Eur Heart J Date: 2010-07-14 Impact factor: 29.983
Authors: Matteo N D Di Minno; Elena Tremoli; Antonio Coppola; Roberta Lupoli; Giovanni Di Minno Journal: Thromb Haemost Date: 2010-03-29 Impact factor: 5.249
Authors: Vikas Veeranna; Sandip K Zalawadiya; Ashutosh Niraj; Jyotiranjan Pradhan; Brian Ference; Robert C Burack; Sony Jacob; Luis Afonso Journal: J Am Coll Cardiol Date: 2011-08-30 Impact factor: 24.094
Authors: A-M Kampoli; D Tousoulis; N Papageorgiou; Z Pallatza; G Vogiatzi; A Briasoulis; E Androulakis; C Toutouzas; P Stougianos; C Tentolouris; C Stefanadis Journal: Curr Med Chem Date: 2012 Impact factor: 4.530
Authors: Manuel Alfonso Baños-González; Eduardo Anglés-Cano; Guillermo Cardoso-Saldaña; Marco Antonio Peña-Duque; Marco Antonio Martínez-Ríos; Benjamin Valente-Acosta; Héctor González-Pacheco; Aurora de la Peña-Díaz Journal: Circ J Date: 2012-05-18 Impact factor: 2.993
Authors: Robert Clarke; Derrick A Bennett; Sarah Parish; Petra Verhoef; Mariska Dötsch-Klerk; Mark Lathrop; Peng Xu; Børge G Nordestgaard; Hilma Holm; Jemma C Hopewell; Danish Saleheen; Toshihiro Tanaka; Sonia S Anand; John C Chambers; Marcus E Kleber; Willem H Ouwehand; Yoshiji Yamada; Clara Elbers; Bas Peters; Alexandre F R Stewart; Muredach M Reilly; Barbara Thorand; Salim Yusuf; James C Engert; Themistocles L Assimes; Jaspal Kooner; John Danesh; Hugh Watkins; Nilesh J Samani; Rory Collins; Richard Peto Journal: PLoS Med Date: 2012-02-21 Impact factor: 11.069